Generous - Support - Pancreatica.org

Partner With Us in the Fight Against Pancreatic Cancer!

Cancer Patients Alliance is a 501(c)(3) nonprofit committed to ending pancreatic cancer through innovation, compassion, and partnerships.

This fight cannot be won alone. It takes a collective effort — a community of passionate donors and allies who believe in making a difference.
Support Pancreatic Cancer Research !

All contributions are tax-deductible. Tax ID # 77-0569948

Together with the strength of partners and allies — we can fund critical research, support families, and bring hope to those facing this devastating disease. Your contribution can lead to breakthroughs in pancreatic cancer early detection, provide vital pancreatic cancer patient support, and fund critical pancreatic cancer education initiatives.

Your pancreatic cancer donation can make a significant impact. By supporting pancreatic cancer research, you help advance early detection methods, improve treatments, and provide essential resources to patients and their families.

“This charity is focused on directly supporting the kind of research I want to support. Research to diagnosis pancreatic cancer at an earlier stage. They have also helped my family find a genetics center for screening”

Cancer Patients Alliance’s websites have been an amazing resource for my family. The medical literature references display an impressive concentration of information on published scientific articles. I will continue to support and volunteer with this great charity and cause.

“We ran a 5K in honor of our grandmother June, Cancer Patients Alliance gave us great resources, information, and encouragement”

📈 Progress and Hope

Recent advancements offer hope:

Improved Survival Rates: The five-year survival rate has increased from 12% to 13%, indicating progress in treatment and early detection.
Innovative Research: Studies are exploring personalized mRNA vaccines and AI-assisted early detection methods to improve outcomes.

Pancreatica is a trusted pancreatic cancer nonprofit, committed to transparency and impact. 94% of our revenue directly supports programs aimed at combating pancreatic cancer.

🔬 Why Your Support Matters

High Mortality Rate: Pancreatic cancer has the highest mortality rate among major cancers
Late Diagnosis: Over 80% of cases are diagnosed at an advanced stage, limiting treatment options
Research Funding: Increased funding is crucial to develop early detection strategies and effective therapies

Trusted By

Additional Resources:

We have created an African American patient education initiative. Our Mission: to provide African American and other pancreatic cancer patients, families, caregivers with skills, knowledge, guidance, and competence to achieve best quality of life and optimal health outcomes.

For our full African-American Patient Guide Educational Module. CLICK HERE

Cancer Patient’s Alliance is proud to have earned a Platinum rating on Guidestar. CLICK HERE

Pancreatic cancer remains one of the most challenging diseases, with a five-year survival rate of just 13%. In 2025, an estimated 67,440 Americans will be diagnosed, and over 51,980 will lose their lives to this illness.

Despite being the 10th most commonly diagnosed cancer, it is the third leading cause of cancer-related deaths in the U.S., projected to become the second by 2030.

Simply select “Monthly” after choosing the amount you would like to give.

Your Legacy of Hope Starts Here

Pancreatic cancer won’t wait—and neither should we. Join our mission to save lives and transform outcomes.

Our Philosophy About Pancreatic Cancer

Pancreatic cancer is a serious disease. Taking an aggressive rational stance at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for survival.

We believe in strong patient-physician bonds, scientifically-based treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done.

That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.

SCIENCE BOARD

James Abbruzzese, MD
Duke University

Markus Büchler, MD
University of Heidelberg, Germany

Ralph Hruban, MD
Johns Hopkins University

Eileen O’Reilly, MD
Memorial Sloan-Kettering

Margaret Tempero, MD
University of California, San Francisco